Several studies have focused on the noninvasive prediction of PD-L1 expression and have developed promising CT or PET/CT radiomic models; however, the sample size of these literatures was small, and most of the subjects were advanced NSCLC patients (24–26). The gene discussed is CD274; the disease is non-small cell lung carcinoma.